A detailed history of Wetherby Asset Management Inc transactions in Grifols Sa stock. As of the latest transaction made, Wetherby Asset Management Inc holds 10,939 shares of GRFS stock, worth $85,542. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,939
Previous 10,255 6.67%
Holding current value
$85,542
Previous $64,000 51.56%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.28 - $9.38 $4,295 - $6,415
684 Added 6.67%
10,939 $97,000
Q2 2024

Aug 14, 2024

SELL
$6.27 - $7.7 $2,658 - $3,264
-424 Reduced 3.97%
10,255 $64,000
Q1 2024

May 15, 2024

SELL
$5.47 - $11.38 $6,460 - $13,439
-1,181 Reduced 9.96%
10,679 $71,000
Q4 2023

Feb 14, 2024

SELL
$7.71 - $11.56 $4,656 - $6,982
-604 Reduced 4.85%
11,860 $137,000
Q3 2023

Nov 14, 2023

SELL
$8.91 - $10.91 $4,847 - $5,935
-544 Reduced 4.18%
12,464 $113,000
Q2 2023

Aug 14, 2023

SELL
$7.14 - $9.29 $46,724 - $60,793
-6,544 Reduced 33.47%
13,008 $119,000
Q1 2023

May 12, 2023

SELL
$6.65 - $10.69 $58,313 - $93,740
-8,769 Reduced 30.96%
19,552 $144,000
Q4 2022

Feb 14, 2023

BUY
$5.96 - $8.53 $99,669 - $142,647
16,723 Added 144.19%
28,321 $240,000
Q3 2022

Nov 14, 2022

SELL
$5.95 - $14.3 $179,933 - $432,446
-30,241 Reduced 72.28%
11,598 $71,000
Q2 2022

Aug 15, 2022

BUY
$10.6 - $13.28 $316,293 - $396,261
29,839 Added 248.66%
41,839 $497,000
Q1 2022

May 16, 2022

BUY
$10.37 - $12.73 $124,439 - $152,760
12,000 New
12,000 $140,000
Q3 2020

Nov 13, 2020

SELL
$15.4 - $20.16 $207,699 - $271,897
-13,487 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$18.24 - $21.45 $19,425 - $22,844
-1,065 Reduced 7.32%
13,487 $246,000
Q1 2020

May 06, 2020

BUY
$16.28 - $25.63 $12,405 - $19,530
762 Added 5.53%
14,552 $294,000
Q4 2019

Jan 28, 2020

SELL
$19.57 - $23.52 $47,046 - $56,542
-2,404 Reduced 14.85%
13,790 $321,000
Q3 2019

Oct 31, 2019

BUY
$19.85 - $22.76 $99 - $113
5 Added 0.03%
16,194 $325,000
Q2 2019

Jul 25, 2019

BUY
$17.59 - $21.1 $14,933 - $17,913
849 Added 5.53%
16,189 $342,000
Q1 2019

May 09, 2019

SELL
$18.01 - $20.11 $19,342 - $21,598
-1,074 Reduced 6.54%
15,340 $309,000
Q4 2018

Jan 30, 2019

SELL
$17.44 - $21.53 $18,556 - $22,907
-1,064 Reduced 6.09%
16,414 $301,000
Q3 2018

Nov 07, 2018

SELL
$19.97 - $21.96 $16,934 - $18,622
-848 Reduced 4.63%
17,478 $373,000
Q2 2018

Jul 24, 2018

SELL
$20.16 - $24.68 $39,211 - $48,002
-1,945 Reduced 9.59%
18,326 $394,000
Q1 2018

May 04, 2018

BUY
$20.31 - $24.95 $18,725 - $23,003
922 Added 4.77%
20,271 $430,000
Q4 2017

Feb 09, 2018

BUY
$20.99 - $23.89 $4,030 - $4,586
192 Added 1.0%
19,349 $444,000
Q3 2017

Nov 13, 2017

BUY
$20.07 - $21.89 $384,480 - $419,346
19,157
19,157 $419,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Wetherby Asset Management Inc Portfolio

Follow Wetherby Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wetherby Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wetherby Asset Management Inc with notifications on news.